Yaser Ghavami1, Yarah M Haidar1, Kasra N Ziai1, Omid Moshtaghi1, Jay Bhatt1, Harrison W Lin1, Hamid R Djalilian1,2. 1. Division of Otology, Neurotology, and Skull Base Surgery, Department of Otolaryngology-Head and Neck Surgery, University of California, Irvine, Irvine, California, U.S.A. 2. Department of Biomedical Engineering, University of California, Irvine, Irvine, California, U.S.A.
Abstract
OBJECTIVE: Mal de debarquement syndrome (MdDS) is a balance disorder that typically starts after an extended exposure to passive motion, such as a boat or plane ride. Management is typically supportive (e.g. physical therapy), and symptoms that persist beyond 6 months have been described as unlikely to remit. This study was conducted to evaluate the response of patients with MdDS to management with migraine prophylaxis, including lifestyle changes and medical therapy. STUDY DESIGN: Prospective review. SETTING: Ambulatory setting at a tertiary care medical center. METHODS: Clinical history, detailed questionnaires, and audiograms were used to diagnose patients with MdDS. Those patients with the diagnosis of the MdDS were placed on our institutional vestibular migraine management protocol. Treatment response was assessed with a quality-of-life (QOL) survey and visual analog scale. RESULTS: Fifteen patients were diagnosed with MdDS, with a predominance of females (73%) and a mean age of 50 ± 13 years. Eleven patients (73%) responded well to management with a vestibular migraine protocol, which included lifestyle changes, as well as pharmacotherapy with verapamil, nortriptyline, topiramate, or a combination thereof. In comparison, a retrospective control group of 17 patients demonstrated a lower rate of improvement when treated with vestibular rehabilitation and physical therapy. CONCLUSION: Management of MdDS as vestibular migraine can improve patients' symptoms and increase the QOL. Nearly all the patients suffering from MdDS had a personal or family history of migraine headaches or had signs or symptoms suggestive of atypical migraine. LEVEL OF EVIDENCE: 4 Laryngoscope, 127:1670-1675, 2017.
OBJECTIVE:Mal de debarquement syndrome (MdDS) is a balance disorder that typically starts after an extended exposure to passive motion, such as a boat or plane ride. Management is typically supportive (e.g. physical therapy), and symptoms that persist beyond 6 months have been described as unlikely to remit. This study was conducted to evaluate the response of patients with MdDS to management with migraine prophylaxis, including lifestyle changes and medical therapy. STUDY DESIGN: Prospective review. SETTING: Ambulatory setting at a tertiary care medical center. METHODS: Clinical history, detailed questionnaires, and audiograms were used to diagnose patients with MdDS. Those patients with the diagnosis of the MdDS were placed on our institutional vestibular migraine management protocol. Treatment response was assessed with a quality-of-life (QOL) survey and visual analog scale. RESULTS: Fifteen patients were diagnosed with MdDS, with a predominance of females (73%) and a mean age of 50 ± 13 years. Eleven patients (73%) responded well to management with a vestibular migraine protocol, which included lifestyle changes, as well as pharmacotherapy with verapamil, nortriptyline, topiramate, or a combination thereof. In comparison, a retrospective control group of 17 patients demonstrated a lower rate of improvement when treated with vestibular rehabilitation and physical therapy. CONCLUSION: Management of MdDS as vestibular migraine can improve patients' symptoms and increase the QOL. Nearly all the patients suffering from MdDS had a personal or family history of migraine headaches or had signs or symptoms suggestive of atypical migraine. LEVEL OF EVIDENCE: 4 Laryngoscope, 127:1670-1675, 2017.
Authors: Zohar Nachum; Avi Shupak; Vadim Letichevsky; Jacob Ben-David; Dror Tal; Ada Tamir; Yoav Talmon; Carlos R Gordon; Michal Luntz Journal: Laryngoscope Date: 2004-03 Impact factor: 3.325
Authors: Angelique Van Ombergen; Vincent Van Rompaey; Leen K Maes; Paul H Van de Heyning; Floris L Wuyts Journal: J Neurol Date: 2015-11-11 Impact factor: 4.849
Authors: V Mucci; J M Canceri; R Brown; M Dai; S Yakushin; S Watson; A Van Ombergen; V Topsakal; P H Van de Heyning; F L Wuyts; C J Browne Journal: J Neurol Date: 2018-01-05 Impact factor: 4.849
Authors: Viviana Mucci; Tyché Perkisas; Steven Douglas Jillings; Vincent Van Rompaey; Angelique Van Ombergen; Erik Fransen; Luc Vereeck; Floris L Wuyts; Paul H Van de Heyning; Cherylea J Browne Journal: Front Neurol Date: 2018-10-25 Impact factor: 4.003
Authors: Viviana Mucci; Josephine M Canceri; Yves Jacquemyn; Angelique Van Ombergen; Leen K Maes; Paul H Van de Heyning; Cherylea J Browne Journal: Future Sci OA Date: 2019-02-21